西点药业：第三季度净利润820.18万元，同比下降14.70%

Core Insights - West Point Pharmaceuticals (301130) reported a decline in revenue and net profit for Q3 2025, indicating potential challenges in the company's financial performance [1] Financial Performance - The company achieved a revenue of 60.63 million yuan in Q3 2025, representing a year-on-year decrease of 4.68% [1] - The net profit for the same period was 8.20 million yuan, reflecting a year-on-year decline of 14.70% [1]